Verve Therapeutics Inc.
5.36
0.11 (2.10%)
At close: Jan 15, 2025, 12:53 PM

Balance Sheet (Annual)

Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year FY23 FY22 FY21 FY20 FY19
Cash & Equivalents 206.18M 115.41M 64.33M 8.99M 2.99M
Short-Term Investments 417.77M 439.40M 296.11M 63.12M 15.80M
Long-Term Investments n/a 4.82M 5.24M 463.00K 235.00K
Other Long-Term Assets 6.94M 585.00K 2.70M n/a n/a
Receivables 5.90M 1.01M n/a n/a n/a
Inventory n/a 1.00 n/a n/a n/a
Other Current Assets 8.10M 7.34M 13.37M 1.85M 272.00K
Total Current Assets 637.95M 563.16M 367.13M 73.97M 19.05M
Property-Plant & Equipment 107.80M 110.66M 9.06M 3.98M 2.36M
Goodwill & Intangibles n/a n/a n/a n/a n/a
Total Long-Term Assets 114.74M 116.06M 17.00M 4.45M 2.59M
Total Assets 752.69M 679.22M 384.12M 78.41M 21.65M
Account Payables 6.64M 2.42M 7.08M 36.00K 2.41M
Deferred Revenue n/a 20.01M -12.99M 90.00K 31.00K
Short-Term Debt 10.19M 23.81M 3.91M n/a n/a
Other Current Liabilities 20.18M 8.86M 11.04M 7.19M 1.11M
Total Current Liabilities 37.01M 35.09M 22.02M 7.32M 3.55M
Long-Term Debt 64.72M 70.01M n/a 125.16M 35.05M
Other Long-Term Liabilities 2.91M 3.17M 4.75M 9.72M 2.46M
Total Long-Term Liabilities 116.18M 93.20M 4.75M 135.01M 37.65M
Total Liabilities 153.19M 128.29M 26.77M 142.32M 41.20M
Total Debt 74.91M 81.92M 1.96M 125.16M 35.05M
Common Stock 82.00K 62.00K 49.00K 3.00K 2.00K
Retained Earnings -544.30M -344.24M -186.85M -66.54M -20.83M
Comprehensive Income 272.00K -694.00K -228.00K 8.00K 9.00K
Shareholders Equity 599.50M 550.93M 357.35M -63.91M -19.55M
Total Investments 417.77M 439.40M 296.11M 63.12M 15.80M